Ignite Creation Date:
2024-10-25 @ 7:50 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06614153
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-09-23
Brief Title:
PharmacokineticsPharmacodynamicsEfficacy and Safety of HRG2010 in Parkinsons Disease Patients With Motor Fluctuations
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Randomized Open-label Controlled Single-dose Multiple-dose Phase II Study to Evaluate the PharmacokineticsPharmacodynamicsEfficacy and Safety of HRG2010 in Parkinsons Disease Patients With Motor Fluctuations
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study is a multicenter randomized open-label active-controlled Phase II clinical study The aim of this trial is to evaluated the pharmacokinetics pharmacodynamicsefficacy and assessed the safety of HRG2010 compared with a sustained-release cabridopa-levodopa formulation in Parkinsons Disease Patients With Motor Fluctuations
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None